Marlboro-Chesterfield Pathology Agrees to Settle Lawsuit Over 2025 Ransomware Attack
Marlboro-Chesterfield Pathology, a molecular, cytology, and pathology lab based in Pinehurst, North Carolina, has agreed to settle a class action lawsuit stemming from a ransomware attack that occurred in 2025. The settlement resolves claims brought by patients whose data was potentially exposed in the breach.
Why this matters: Pathology labs hold some of the most sensitive medical data that exists — tissue samples, cancer diagnoses, genetic results, the kind of information people barely want to say out loud. When that data gets stolen, patients do not just face spam. They face potential exposure of conditions they may not have shared with anyone. A settlement means the lab avoids a full legal reckoning. It also means patients get something, but rarely enough to reflect what it actually costs to have your most private health details taken. The real accountability question is whether labs handling this kind of data are building security proportionate to the risk, or just hoping ransomware finds someone else first.
Who should care: Cybersecurity · Privacy officers · Administrators · Lawyers · Compliance · Healthcare professionals
This summary is AI-assisted and may contain errors. It is an original briefing to help you gauge significance quickly — not a reproduction of the source. Always read the linked original before relying on it. See our methodology.